1. Home
  2. TIL vs MPU Comparison

TIL vs MPU Comparison

Compare TIL & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • MPU
  • Stock Information
  • Founded
  • TIL 2018
  • MPU 1989
  • Country
  • TIL United States
  • MPU Singapore
  • Employees
  • TIL N/A
  • MPU N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • MPU Transportation Services
  • Sector
  • TIL Health Care
  • MPU Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • MPU Nasdaq
  • Market Cap
  • TIL 230.1M
  • MPU 35.5M
  • IPO Year
  • TIL 2021
  • MPU 1998
  • Fundamental
  • Price
  • TIL $23.87
  • MPU $2.01
  • Analyst Decision
  • TIL Buy
  • MPU
  • Analyst Count
  • TIL 5
  • MPU 0
  • Target Price
  • TIL $119.00
  • MPU N/A
  • AVG Volume (30 Days)
  • TIL 310.5K
  • MPU 1.2M
  • Earning Date
  • TIL 08-12-2025
  • MPU 08-13-2025
  • Dividend Yield
  • TIL N/A
  • MPU N/A
  • EPS Growth
  • TIL N/A
  • MPU N/A
  • EPS
  • TIL N/A
  • MPU N/A
  • Revenue
  • TIL N/A
  • MPU $35,228,600.00
  • Revenue This Year
  • TIL N/A
  • MPU N/A
  • Revenue Next Year
  • TIL N/A
  • MPU N/A
  • P/E Ratio
  • TIL N/A
  • MPU N/A
  • Revenue Growth
  • TIL N/A
  • MPU 305.32
  • 52 Week Low
  • TIL $9.85
  • MPU $0.49
  • 52 Week High
  • TIL $92.00
  • MPU $2.67
  • Technical
  • Relative Strength Index (RSI)
  • TIL 46.54
  • MPU 62.83
  • Support Level
  • TIL $23.38
  • MPU $1.82
  • Resistance Level
  • TIL $26.91
  • MPU $2.25
  • Average True Range (ATR)
  • TIL 3.25
  • MPU 0.36
  • MACD
  • TIL -0.32
  • MPU 0.07
  • Stochastic Oscillator
  • TIL 31.75
  • MPU 64.57

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MPU Mega Matrix Corp.

Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: